Designer drugs: mechanism of action and adverse effects
Open accessThe DOI matches its Crossref record; 658 of the 659 references it cites were found in a registry or an index.
Abstract
Psychoactive substances with chemical structures or pharmacological profiles that are similar to traditional drugs of abuse continue to emerge on the recreational drug market. Internet vendors may at least temporarily sell these so-called designer drugs without adhering to legal statutes or facing legal consequences. Overall, the mechanism of action and adverse effects of designer drugs are similar to traditional drugs of abuse. Stimulants, such as amphetamines and cathinones, primarily interact with monoamine transporters and mostly induce sympathomimetic adverse effects. Agonism at μ-opioid receptors and γ-aminobutyric acid-A (GABA A ) or GABA B receptors mediates the pharmacological effects of sedatives, which may induce cardiorespiratory depression. Dissociative designer drugs primarily act as N -methyl- d -aspartate receptor antagonists and pose similar health risks as the medically approved dissociative anesthetic ketamine. The cannabinoid type 1 (CB 1 ) receptor is thought to drive the psychoactive effects of synthetic cannabinoids, which are associated with a less desirable effect profile and more severe adverse effects compared with cannabis. Serotonergic 5-hydroxytryptamine-2A (5-HT 2A ) receptors mediate alterations of perception and cognition that are induced by serotonergic psychedelics. Because of their novelty, designer drugs may remain undetected by routine drug screening, thus hampering evaluations of adverse effects. Intoxication reports suggest that several designer drugs are used concurrently, posing a high risk for severe adverse effects and even death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The precipitous increase in novel and designer drugs (eg, cathinones, amphetamines) in the market complicates the clinical picture.3”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 658
Synthetic Cannabis and Respiratory Depression
Jinwala, F., & Gupta, M. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0122 · Cited by 50
Fatal Intoxication with Methoxetamine
Adamowicz, P., & Zuba, D. (2014) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12594 · Cited by 50
NBOMe Designer Drug Exposures Reported to Texas Poison Centers
Forrester, M. B. (2014) · Journal of Addictive Diseases · doi:10.1080/10550887.2014.950027 · Cited by 50
Koch, K., Auwärter, V., Hermanns‐Clausen, M., Wilde, M., & Neukamm, M. A. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2391 · Cited by 50
Bonaccorso, S., Metastasio, A., Ricciardi, A., Stewart, N., Jamal, L., Rujully, N.-U.-D., Theleritis, C. G., Ferracuti, S., Ducci, G., & Schifano, F. (2018) · Brain Sciences · doi:10.3390/brainsci8070133 · Cited by 50
Novel Synthetic Opioids: The Pathologist’s Point of View
Frisoni, P., Bacchio, E., Bilel, S., Talarico, A., Gaudio, R. M., Barbieri, M., Neri, M., & Marti, M. (2018) · Brain Sciences · doi:10.3390/brainsci8090170 · Cited by 50
1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
Wallach, J. V., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_148 · Cited by 50
Al-Matrouk, A. K., Alqallaf, M., AlShemmeri, A., & Bojbarah, H. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.109960 · Cited by 50
Chan, W. L., Wood, D. M., Hudson, S. C., & Dargan, P. I. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0306-y · Cited by 49
Forsling, M., Fallon, J. K., Kicman, A. T., Hutt, A. J., Cowan, D. A., & Henry, J. A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777855 · Cited by 49
Morse, B. L., Vijay, N., & Morris, M. E. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078154 · Cited by 49
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings
Berkowitz, E. A., Henry, T. S., Veeraraghavan, S., Staton, G. W., & Gal, A. A. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.14.13138 · Cited by 48
Toxicity and death following recreational use of 2-pyrrolidino valerophenone
Eiden, C., Mathieu, O., Cathala, P., Debruyne, D., Baccino, É., Petit, P., & Peyrière, H. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.847187 · Cited by 48
Designer benzodiazepines’ pharmacological effects and potencies: How to find the information
Balkhi, S. E., Monchaud, C., Herault, F., Geniaux, H., & Saint‐Marcoux, F. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119901096 · Cited by 48
Lonkhuyzen, J. J. N., van Riel, A. J. H. P., Brunt, T. M., & Hondebrink, L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.011 · Cited by 47
Adolescent Synthetic Cannabinoid Exposures Reported to Texas Poison Centers
Forrester, M. B. (2012) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31826c9a97 · Cited by 47
Driving under the influence of synthetic phenethylamines: a case series
Maas, A., Wippich, C., Madea, B., & Heß, C. (2015) · International Journal of Legal Medicine · doi:10.1007/s00414-015-1150-1 · Cited by 47
Dargan, P. I., Tang, H. C., Liang, W., Wood, D. M., & Yew, D. T. W. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.892605 · Cited by 47
Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
Dias-da-Silva, D., Arbo, M. D., Valente, M. J., Bastos, M. D. L., & Carmo, H. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.04.001 · Cited by 47
High incidence of mild hyponatraemia in females using ecstasy at a rave party
Dijken, G. D. V., Blom, R. E., Hené, R. J., Boer, W. H., & NIGRAM Consortium (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft023 · Cited by 47
Liveri, K., Constantinou, M. A., Afxentiou, M., & Kanari, P. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.02.017 · Cited by 47
Clinical Presentation, Autopsy Results and Toxicology Findings in an Acute N-Ethylpentylone Fatality
Thirakul, P., S. Hair, L., L. Bergen, K., & M. Pearson, J. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx004 · Cited by 47
Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption
Kovács, K., Kereszty, É. M., Berkecz, R., Tiszlavicz, L., Sija, É., Körmöczi, T., Jenei, N., Révész-Schmehl, H., & Institóris, L. (2019) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2019.04.012 · Cited by 47
Synthetic Cannabinoid Induced Psychosis in a Previously Nonpsychotic Patient
Peglow, S. L., Buchner, J. A., & Briscoe, G. W. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00222.x · Cited by 46
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients
Clark, B. C., Georgekutty, J., & Berul, C. I. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.06.001 · Cited by 46
Diethylpropion in the Treatment of "Refractory" Obesity
Seaton, D. A., Duncan, L. J. P., Rose, K., & Scott, A. M. (1961) · BMJ · doi:10.1136/bmj.1.5231.1009 · Cited by 46
Garbino, J., Henry, J. A., Mentha, G., & Romand, J. A. (2001) · Clinical cornerstone · doi:10.1016/s1098-3597(01)90081-x · Cited by 46
Evaluation of pyrovalerone in chronically fatigued volunteers.
Gárdos, G., & Jo, C. (1971) · PubMed · Cited by 46
Zarifi, C., & Vyas, S. (2017) · The Permanente Journal · doi:10.7812/tpp/16-160 · Cited by 46
Pant, S., Dholaria, B., Kaur, V., Ramavaram, S., Ukor, M., Deshmukh, A. J., & Teran, G. A. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31824cf5c2 · Cited by 46
Herian, M., Wojtas, A., Kamińska, K., Świt, P., Wach, A., & Gołembiowska, K. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00033-x · Cited by 46
Boland, D. M., Reidy, L. J., Seither, J. Z., Radtke, J. M., & Lew, E. O. (2019) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14098 · Cited by 46
Twenty‐three deaths with γ‐hydroxybutyrate overdose in western Sweden between 2000 and 2007
Knudsen, K., Jonsson, U., & Abrahamsson, J. (2010) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2010.02278.x · Cited by 45
Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY
Wood, D. M., Looker, J. J., Shaikh, L. A. H. A., Button, J., Puchnarewicz, M., Davies, S., Lidder, S., Ramsey, J. M., Holt, D. W., & Dargan, P. I. (2009) · Journal of Medical Toxicology · doi:10.1007/bf03178273 · Cited by 45
Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J. V., Stratford, A., Nichols, D. E., & Halberstadt, A. L. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2196 · Cited by 45
Andersson, M., & Kjellgren, A. (2017) · Nordic Studies on Alcohol and Drugs · doi:10.1177/1455072517706304 · Cited by 45
Luethi, D., Hoener, M. C., & Liechti, M. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.012 · Cited by 45
Self-citationPostmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug
Fels, H., Lottner-Nau, S., Sax, T., Roider, G., Graw, M., Auwärter, V., & Mußhoff, F. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.04.010 · Cited by 45
Bäckberg, M., Beck, O., Hultén, P., Rosengren-Holmberg, J. P., & Helander, A. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.920088 · Cited by 44
Smoking Synthetic Marijuana Leads to Self-Mutilation Requiring Bilateral Amputations
Meijer, K. A., Russo, R. R., & Adhvaryu, D. V. (2014) · Orthopedics · doi:10.3928/01477447-20140401-62 · Cited by 44
2C‐T‐4 intoxication: Acute psychosis caused by a designer drug
Miyajima, M., Matsumoto, T., & Ito, S. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01764.x · Cited by 44
Identification and Quantification of Alpha-Methylfentanyl in Post Mortem Specimens
Gillespie, T. J., Gandolfi, A. J., Davis, T. P., & Morano, R. (1982) · Journal of Analytical Toxicology · doi:10.1093/jat/6.3.139 · Cited by 44
Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-47700
Ellefsen, K. N., Taylor, E., Simmons, P., Willoughby, V., & Hall, B. J. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx060 · Cited by 44
Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature
Öztürk, H. M., Yetkın, E., & Öztürk, S. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09522-z · Cited by 44
Jebadurai, J. K., Schifano, F., & Deluca, P. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2302 · Cited by 43
Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids
Sweeney, B., Talebi, S., Toro, D. R. D., Gonzalez, K., Menoscal, J.-P., Shaw, R., & Hassen, G. W. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.05.052 · Cited by 43
Effects of opioids on human serotonin transporters
Barann, M., Stamer, U. M., Lyutenska, M., Stüber, F., Bönisch, H., & Urban, B. W. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1056-3 · Cited by 43
Derungs, A., Steuer, A. E., Mansella, G., Bingisser, R. M., Kræmer, T., & Liechti, M. E. (2012) · Forensic Toxicology · doi:10.1007/s11419-012-0166-1 · Cited by 43
Self-citationAcute Effects of the Novel Psychoactive Drug 2C-B on Emotions
González, D., Torrens, M., & Farré, M. (2015) · BioMed Research International · doi:10.1155/2015/643878 · Cited by 43
A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
Johansson, A., Lindstedt, D., Roman, M., Thelander, G., Nielsen, E. I., Lennborn, U., Sandler, H., Rubertsson, S., Ahlner, J., Kronstrand, R., et al. (2017) · Forensic Science International · doi:10.1016/j.forsciint.2017.02.034 · Cited by 43
Klein, L. M., Cozzi, N. V., Daley, P. F., Brandt, S. D., & Halberstadt, A. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.028 · Cited by 43
Mensen, V. T., Vreeker, A., Nordgren, J., Atkinson, A. M., de la Torre, R., Farré, M., Ramaekers, J. G., & Brunt, T. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05238-8 · Cited by 43
Suicidal ideation and self-harm following K2 use.
Thomas, S., Bliss, S., & Malik, M. (2012) · PubMed · Cited by 42
Acute liver failure following intravenous methamphetamine.
Kamijo, Y., Soma, K., Nishida, M., Namera, A., & Ohwada, T. (2002) · PubMed · Cited by 42
Recreational Use of Aminorex and Pulmonary Hypertension
Gaine, S. P., Rubin, L. J., Kmetzo, J. J., Palevsky, H. I., & Traill, T. A. (2000) · CHEST Journal · doi:10.1378/chest.118.5.1496 · Cited by 42
The Secret “Spice”: An Undetectable Toxic Cause of Seizure
de Havenon, A., Chin, B. M., Thomas, K. C., & Afra, P. (2011) · The Neurohospitalist · doi:10.1177/1941874411417977 · Cited by 42
Phencyclidine-Based New Psychoactive Substances
Wallach, J. V., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_124 · Cited by 42
McIlroy, G., Ford, L. T., & Khan, J. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0045-1 · Cited by 41
Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method
Bakota, E. L., Arndt, C., Romoser, A. A., & Wilson, S. K. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw056 · Cited by 41
Silva, J. P., Carmo, H., & Carvalho, F. D. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.01.023 · Cited by 41
McIntyre, I. M., Gary, R. D., Trochta, A., Stolberg, S., & Stabley, R. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku131 · Cited by 40
“Designer drugs” — A current perspective
Jerrard, D. A. (1990) · Journal of Emergency Medicine · doi:10.1016/0736-4679(90)90288-7 · Cited by 40
NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System
Srisuma, S., Bronstein, A. C., & Hoyte, C. O. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1054502 · Cited by 40
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis
Khan, M., Pace, L. A., Truong, A. L., Gordon, M., & Moukaddam, N. J. (2015) · American Journal on Addictions · doi:10.1111/ajad.12318 · Cited by 40
Synthetic Aminoindanes: A Summary of Existing Knowledge
Pinterová, N., Horsley, R. R., & Páleníček, T. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00236 · Cited by 40
A Fatality Involving U4Euh, A Cyclic Derivative of Phenylpropanolamine
Davis, F., & Brewster, M. (1988) · Journal of Forensic Sciences · doi:10.1520/jfs11971j · Cited by 39
Hospitalisation associated with use of the synthetic cannabinoid K2.
Glue, P., Al‐Shaqsi, S., Hancock, D., Gale, C. K., Strong, B., & Schep, L. J. (2013) · PubMed · Cited by 39
Designer drugs in herbal aphrodisiacs
Venhuis, B. J., Blok‐Tip, L., & de Kaste, D. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2007.11.007 · Cited by 39
Sherpa, D., Paudel, B. M., Subedi, B. H., & Chow, R. D. (2015) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v5.27540 · Cited by 39
Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review
Hobbs, M., Kalk, N. J., Morrison, P. D., & Stone, J. M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.004 · Cited by 39
Luethi, D., Walter, M., Zhou, X. C., Rudin, D., Krähenbühl, S., & Liechti, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00438 · Cited by 39
Self-citationLuethi, D., Kolaczynska, K. E., Walter, M., Suzuki, M., Rice, K. C., Blough, B. E., Hoener, M. C., Baumann, M. H., & Liechti, M. E. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119844185 · Cited by 39
Self-citationBrandt, S. D., Baumann, M. H., Partilla, J. S., Kavanagh, P. V., Power, J. D., Talbot, B. N., Twamley, B., Mahony, O., O'Brien, J., Elliott, S. P., et al. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1668 · Cited by 38
Blood Levels of 3-Methylfentanyl in 3 Fatal Poisoning Cases
Ojanperä, I. A., Gergov, M., Rasanen, I., Lunetta, P., Toivonen, S., Tiainen, E., & Vuori, E. (2006) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000188097.78132.e5 · Cited by 38
Acute liver failure following recreational use of psychotropic “head shop” compounds
Fröhlich, S., Lambe, E., & O’Dea, J. (2010) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-010-0636-6 · Cited by 38
Arbo, M. D., Silva, R., Barbosa, D. J., da Silva, D. D., Silva, S. P., Teixeira, J. P., Bastos, M. D. L., & Carmo, H. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3153 · Cited by 38
Synthetic Cannabinoid Leading to Cannabinoid Hyperemesis Syndrome
Bick, B. L., Szostek, J. H., & Mangan, T. F. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.06.013 · Cited by 38
A review of ethylphenidate in deaths in east and west Scotland
Parks, C., McKeown, D. A., & Torrance, H. J. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.08.008 · Cited by 38
Analysis of phenazepam and 3‐hydroxyphenazepam in post‐mortem fluids and tissues
Crichton, M. L., Shenton, C. F., Drummond, G., Beer, L. J. Z., Seetohul, L. N., & Maskell, P. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1790 · Cited by 38
Four Fatalities Involving 5-IT
Seetohul, L. N., & Pounder, D. J. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt053 · Cited by 38
Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure
Argamany, J. R., Reveles, K. R., & Duhon, B. M. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.08.051 · Cited by 38
da Silva, D. D., Silva, M. J., Moreira, P., Martins, M. J., Valente, M. J., Carvalho, F. D., Bastos, M. D. L., & Carmo, H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1777-9 · Cited by 38
Dwyer, J. B., Janssen, J. K., Luckasevic, T. M., & Williams, K. E. (2017) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13517 · Cited by 38
Hondebrink, L., Lonkhuyzen, J. J. N., Rietjens, S. J., Brunt, T. M., Venhuis, B. J., Soerdjbalie‐Maikoe, V., Smink, B. E., van Riel, A. J. H. P., & de Vries, I. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.07.482 · Cited by 38
Acute methoxetamine and amphetamine poisoning with fatal outcome: A case report
Wiergowski, M., Anand, J. S., Krzyżanowski, M., & Jankowski, Z. (2014) · International Journal of Occupational Medicine and Environmental Health · doi:10.2478/s13382-014-0290-8 · Cited by 37
Johnson, M. P., Xuemei, H., Oberlender, R. A., Nash, J. F., & Nichols, D. E. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94090-k · Cited by 37
Troxler, F., & Hofmann, A. A. (1957) · Helvetica Chimica Acta · doi:10.1002/hlca.19570400619 · Cited by 37
Determining the subjective and physiological effects of BZP combined with TFMPP in human males
Lin, J. C., Jan, R. K., Lee, H., Jensen, M., Kydd, R. R., & Russell, B. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2081-7 · Cited by 37
Ecstacy-associated hyponatremia: why are women at risk?
Moritz, M. L., Kalantar‐Zadeh, K., & Ayus, J. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft192 · Cited by 37
Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases
Usui, K., Fujita, Y., Kamijo, Y., Kokaji, T., & Funayama, M. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx088 · Cited by 37
Synthetic Cathinone Exposures Reported to Texas Poison Centers
Forrester, M. B. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.677890 · Cited by 36
Persistent psychosis after ingestion of a single tablet of ‘2C-B’
Huang, H.-H., & Bai, Y. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.018 · Cited by 36
Synthetic Cannabinoid‐Associated Multiple Organ Failure: Case Series and Literature Review
Armstrong, F., McCurdy, M. T., & Heavner, M. S. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2241 · Cited by 36
Custodio, R. J. P., Sayson, L. V., Botanas, C. J., Abiero, A., You, K. Y., Kim, M., Lee, H. J., Yoo, S. Y., Lee, K. W., Lee, Y. S., et al. (2019) · Addiction Biology · doi:10.1111/adb.12850 · Cited by 36
Halberstadt, A. L. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.01.005 · Cited by 35
Arbo, M. D., Melega, S., Stöber, R. M., Schug, M., Rempel, E., Rahnenführer, J., Godoy, P., Reif, R., Cadenas, C., Bastos, M. D. L., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1665-3 · Cited by 35
3-Methylmethcathinone—Interpretation of Blood Concentrations Based on Analysis of 95 Cases
Adamowicz, P., Gieroń, J., Gil, D., Lechowicz, W., Skulska, A., & Tokarczyk, B. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw018 · Cited by 35
Analytical Findings of an Acute Intoxication after Inhalation of Methoxetamine
Imbert, L., Boucher, A., Delhome, G., Cueto, T., Boudinaud, M., Maublanc, J., Dulaurent, S., Descotes, J., Lachâtre, G., & Gaulier, J. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku052 · Cited by 35
Clinical characteristics of α-pyrrolidinovalerophenone (α-PVP) poisoning
Umebachi, R., Aoki, H., Sugita, M., Taira, T., Wakai, S., Saito, T., & Inokuchi, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2016.1166508 · Cited by 35
Aarde, S. M., & Taffe, M. A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_54 · Cited by 35
A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
Ivanov, I. D., Stoykova, S., Ivanova, E., Vlahova, A. I., Burdzhiev, N. T., Pantcheva, I. N., & Atanasov, V. N. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.02.005 · Cited by 35
Zhao, A., Tan, M., Maung, A., Salifu, M. O., & Mallappallil, M. C. (2015) · Case Reports in Nephrology · doi:10.1155/2015/235982 · Cited by 34
Hofer, K. E., Degrandi, C., Müller, D. M., Zürrer‐Härdi, U., Wahl, S., Rauber‐Lüthy, C., & Ceschi, A. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.974264 · Cited by 34
The effects of synthetic cannabinoid UR-144 on the human body—A review of 39 cases
Adamowicz, P., Gieroń, J., Gil, D., Lechowicz, W., Skulska, A., & Tokarczyk, B. (2017) · Forensic Science International · doi:10.1016/j.forsciint.2017.02.031 · Cited by 34
Phenibut exposures and clinical effects reported to a regional poison center
Mccabe, D. J., Bangh, S. A., Arens, A. M., & Cole, J. B. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.02.044 · Cited by 34
Hepatocellular Damage Following Amphetamine Intoxication
Jones, A. L., Jarvie, D. R., McDermid, G., & Proudfoot, A. T. (1994) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659409011046 · Cited by 33
Two Fatal Intoxications Involving 3-Methoxyphencyclidine
Mitchell-Mata, C. L., Thomas, B., Peterson, B. L., & Couper, F. J. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx048 · Cited by 33
Ethylone-Related Deaths: Toxicological Findings
Lee, D., Chronister, C. W., Hoyer, J. L., & Goldberger, B. A. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv053 · Cited by 32
Cerebral Vasculopathy After 4-Bromo-2,5-Dimethoxyphenethylamine Ingestion
Ambrose, J. B., Bennett, H. D., Lee, H. S., & Josephson, S. A. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181a3cb53 · Cited by 32
Agitation is common in γ-hydroxybutyrate toxicity
Zvosec, D. L., & Smith, S. W. (2005) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2005.02.003 · Cited by 32
Hamilton, R. J., Keyfes, V., & Banka, S. S. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.09.023 · Cited by 32
Ketamine Analog Methoxetamine Induced Inflammation and Dysfunction of Bladder in Rats
Wang, Q., Wu, Q., Wang, J., Chen, Y., Zhang, G., Chen, J., Zhao, J., & Wu, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010117 · Cited by 32
New psychoactive substances: Purchasing and supply patterns in Australia
Sutherland, R., Bruno, R., Peacock, A., Dietze, P., Breen, C. L., Burns, L., & Barratt, M. J. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2577 · Cited by 32
Babi, M.-A., Robinson, C. P., & Maciel, C. B. (2017) · SAGE Open Medical Case Reports · doi:10.1177/2050313x17745206 · Cited by 32
da Silva, D. D., Ferreira, B., Bravo, R. R., Rebelo, R., de Almeida, T. D., Valente, M. J., Silva, J. P., Carvalho, F. D., Bastos, M. D. L., & Carmo, H. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02539-x · Cited by 32
Eede, H. V., Montenij, L. J., Touw, D. J., & Norris, E. (2009) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2009.04.057 · Cited by 31
Lee, H. M. D., Wood, D. M., Hudson, S. C., Archer, J. R. H., & Dargan, P. I. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-014-0399-y · Cited by 31
Ecstasy-Associated Acute Severe Hyponatremia and Cerebral Edema: A Role for Osmotic Diuresis?
Ghatol, A., & Kazory, A. (2009) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2009.05.001 · Cited by 31
A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure
Gudsoorkar, V. S., & Perez, J. A. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-3-189 · Cited by 31
Páleníček, T., Lhotková, E., Žídková, M., Balíková, M., Kuchař, M., Himl, M., Cihlářová, P., Čegan, M., Valeš, K., Tylš, F., et al. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.004 · Cited by 31
Ischemic stroke associated with the use of a synthetic cannabinoid (spice)
Moeller, S., Lücke, C., Struffert, T., Schwarze, B., Gerner, S. T., Schwab, S., Köhrmann, M., Machold, K., Philipsen, A., & Müller, H. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.10.019 · Cited by 31
Synthetic Cannabinoid Overdose in a 20-Year-Old Male US Soldier
Berry-Cabán, C. S., Ee, J. S., Ingram, V., Berry, C. E., & Kim, E. H. (2013) · Substance Abuse · doi:10.1080/08897077.2012.677754 · Cited by 30
First detection of ethylphenidate in human fatalities after ethylphenidate intake
Krueger, J., Sachs, H., Mußhoff, F., Dame, T., Schaeper, J., Schwerer, M. J., Graw, M., & Roider, G. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.07.017 · Cited by 30
McIntyre, I. M., Trochta, A., Gary, R. D., Storey, A., Corneal, J., & Schaber, B. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv089 · Cited by 30
Mayer, F. P., Burchardt, N., Decker, A. M., Partilla, J. S., Li, Y., McLaughlin, G., Kavanagh, P. V., Sandtner, W., Blough, B. E., Brandt, S. D., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.006 · Cited by 30
Mono-/polyintoxication with 5F-ADB: A case series
Krämer, M., Fels, H., Dame, T., Mußhoff, F., Halter, S., Mogler, L., Heß, C., Madea, B., & Maas, A. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.05.017 · Cited by 30
Kolaczynska, K. E., Luethi, D., Trachsel, D., Hoener, M. C., & Liechti, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01423 · Cited by 30
Self-citationEcstasy-induced rhabdomyolysis and its role in the development of acute renal failure
Cunningham, M. (1997) · Intensive and Critical Care Nursing · doi:10.1016/s0964-3397(97)80056-0 · Cited by 29
Adamowicz, P., & Lechowicz, W. (2015) · Traffic Injury Prevention · doi:10.1080/15389588.2015.1018990 · Cited by 29
Burish, M. J., Thoren, K. L., Madou, M. R. Z., Toossi, S., & Shah, M. (2014) · The Neurohospitalist · doi:10.1177/1941874414528939 · Cited by 29
Comparing fatal cases involving U-47700
Ruan, X., Chiravuri, S., & Kaye, A. D. (2016) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-016-9795-8 · Cited by 29
Silva, J. P., Araújo, A. M., de Pinho, P. G., Carmo, H., & Carvalho, F. D. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz050 · Cited by 29
para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter
Niello, M., Cintulová, D., Hellsberg, E., Jäntsch, K., Holy, M., Ayatollahi, L. H., Cozzi, N. V., Freissmuth, M., Sandtner, W., Ecker, G. F., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.021 · Cited by 29
Grumann, C., Henkel, K., Stratford, A., Hermanns‐Clausen, M., Passie, T., Brandt, S. D., & Auwärter, V. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.05.062 · Cited by 29
Synthetic marijuana use and development of catatonia in a 17-year-old male.
Smith, D. L., & Roberts, C. (2014) · PubMed · Cited by 28
Roberto, A. J., Lorenzo, A., Li, K. J., Young, J., Mohan, A., Pinnaka, S., & Lapidus, K. A. B. (2016) · Case Reports in Psychiatry · doi:10.1155/2016/7257489 · Cited by 28
Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine
Žídková, M., Hložek, T., Balík, M., Kopecký, O., Tesinsky, P., Svanda, J., & Balı́ková, M. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx009 · Cited by 28
Fatal case of poisoning with a new cathinone derivative: α-propylaminopentiophenone (N-PP)
Majchrzak, M., Celiński, R., Kowalska, T., & Sajewicz, M. (2018) · Forensic Toxicology · doi:10.1007/s11419-018-0417-x · Cited by 28
Nash, C., Butzbach, D. M., Stockham, P. C., Scott, T., Abroe, G., Painter, B., Gilbert, J., & Kostakis, C. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky099 · Cited by 28
Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid
Wilde, M., Sommer, M. J., Auwärter, V., & Hermanns‐Clausen, M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.11.025 · Cited by 28
Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts
Zhou, X. C., Luethi, D., Sanvee, G. M., Bouitbir, J., Liechti, M. E., & Krähenbühl, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071561 · Cited by 28
Self-citationA novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents
Seo, J., Hur, K., Ko, Y., Kim, K., Lee, B., Kim, Y., Kim, S., Kim, S., Lee, Y. S., Kim, H., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.002 · Cited by 28
Devgun, J. M., Rasin, A., Kim, T., Mycyk, M. B., Bryant, S. M., Wahl, M., DesLauriers, C., Navon, L., Moritz, E. D., Thompson, T. M., et al. (2019) · Clinical Toxicology · doi:10.1080/15563650.2019.1690149 · Cited by 28
New Drugs of Abuse Update: Foxy Methoxy
Muller, A. A. (2004) · Journal of Emergency Nursing · doi:10.1016/j.jen.2004.07.037 · Cited by 27
A Cluster of Deaths Involving 5-(2-Aminopropyl)Indole (5-IT)
Kronstrand, R., Roman, M., Dahlgren, M., Thelander, G., Wikstrom, M., & Druid, H. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt058 · Cited by 27
Seven fatalities associated with ethylphenidate
Maskell, P., Smith, P. R., Cole, R., Hikin, L., & Morley, S. R. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2015.12.045 · Cited by 27
Benzylpiperazine: “A messy drug”
Katz, D. P., DeRuiter, J., Bhattacharya, D., Ahuja, M., Bhattacharya, S., Clark, C. R., Suppiramaniam, V. D., & Dhanasekaran, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.010 · Cited by 27
Liakoni, E., Walther, F., Nickel, C. H., & Liechti, M. E. (2016) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-016-0299-z · Cited by 27
Self-citationWagmann, L., Brandt, S. D., Stratford, A., Maurer, H. H., & Meyer, M. R. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2494 · Cited by 27
Halberstadt, A. L., Chatha, M., Stratford, A., Grill, M., & Brandt, S. D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.037 · Cited by 27
Synthetic Cathinones and Their Potential Interactions with Prescription Drugs
Contrucci, R. R., Brunt, T. M., Inan, F., Franssen, E. J. F., & Hondebrink, L. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000682 · Cited by 27
Sudden cardiac death complicating acute myocardial infarction following synthetic cannabinoid use
Tse, R. D., Kodur, S., Squires, B., & Collins, N. J. (2014) · Internal Medicine Journal · doi:10.1111/imj.12521 · Cited by 26
Herraiz, T., & Brandt, S. D. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1530 · Cited by 26
Death due to intravenous use of α‐pyrrolidinopentiophenone
Sellors, K., Jones, A., & Chan, B. S. H. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.00203 · Cited by 26
Repeated Thrombosis After Synthetic Cannabinoid Use
Raheemullah, A., & Laurence, T. N. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.06.015 · Cited by 26
Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
Yeruva, R. R., Mekala, H. M., Sidhu, M., & Lippmann, S. (2019) · PubMed Central · Cited by 26
Marusich, J. A., Antonazzo, K. R., Blough, B. E., Brandt, S. D., Kavanagh, P. V., Partilla, J. S., & Baumann, M. H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.004 · Cited by 25
Acute rhabdomyolysis following synthetic cannabinoid ingestion
Adedinsewo, D. A., Odewole, O. A., & Todd, T. (2016) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.185038 · Cited by 25
Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines
Thornton, S. L., Lisbon, D. P., Lin, T. S., & Gerona, R. R. L. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1333660 · Cited by 25
Suyama, J. A., Banks, M. L., & Negus, S. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5029-y · Cited by 25
Müller, D., Neurath, H., Neukamm, M. A., Wilde, M., Despicht, C., Blaschke, S., & Grapp, M. (2019) · Clinical Toxicology · doi:10.1080/15563650.2018.1554187 · Cited by 25
Hallucinogen persisting perception disorder: A literature review and three case reports
Skryabin, V. Y., Vinnikova, M., Nenastieva, A., & Alekseyuk, V. (2018) · Journal of Addictive Diseases · doi:10.1080/10550887.2019.1673655 · Cited by 25
5-iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine
Nichols, D. E., Johnson, M. P., & Oberlender, R. A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90601-w · Cited by 24
Miller, K. J., Anderholm, D. C., & Ames, M. M. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90332-1 · Cited by 24
Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus
Hermanns‐Clausen, M., Angerer, V., Kithinji, J., Grumann, C., & Auwärter, V. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1319572 · Cited by 24
Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study
Welter, S., Lücke, C., Lam, A. P., Custal, C., Moeller, S., Sörös, P., Thiel, C. M., Philipsen, A., & Müller, H. (2017) · European Addiction Research · doi:10.1159/000479554 · Cited by 24
Dunlop, L. C., Wood, D. M., Archer, J. R. H., Hudson, S. C., & Dargan, P. I. (2019) · Journal of Medical Toxicology · doi:10.1007/s13181-019-00734-x · Cited by 24
A Fatal Case of Isolated Methiopropamine (1-(Thiophen-2-yl)-2-Methylaminopropane) Toxicity
Anne, S., Tse, R. D., & Cala, A. D. (2015) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000170 · Cited by 23
Bäckberg, M., Westerbergh, J., Beck, O., & Helander, A. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1211288 · Cited by 23
Maier, J., Mayer, F. P., Luethi, D., Holy, M., Jäntsch, K., Reither, H., Hirtler, L., Hoener, M. C., Liechti, M. E., Pifl, C., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.018 · Cited by 23
Self-citationLuethi, D., Widmer, R., Trachsel, D., Hoener, M. C., & Liechti, M. E. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.014 · Cited by 23
Self-citationHo, J. H., Bailey, G. P., Archer, J. R. H., Dargan, P. I., & Wood, D. M. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1906-z · Cited by 22
Coppola, M., & Mondola, R. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.01.008 · Cited by 22
Liver transplantation for ecstasy-induced fulminant hepatic failure
Carlis, L. G. D., GASPERI, A. D., Slim, A. O., Giacomoni, A., Corti, A., Mazza, E., Benedetto, F. D., Lauterio, A., Arcieri, K., Maione, G., et al. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02176-5 · Cited by 22
The experience of an increase in the injection of ethylphenidate in Lothian April 2014–March 2015
Lafferty, C., Smith, L. A., Coull, A. F., & Shanley, J. (2016) · Scottish Medical Journal · doi:10.1177/0036933016649871 · Cited by 22
Acute toxic effects related to 4-fluoroamphetamine
Wijers, C. H. W., van Litsenburg, R. T. H., Hondebrink, L., Niesink, R. J. M., & Croes, E. A. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30281-7 · Cited by 22
Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile
Coney, L., Maier, L. J., Ferris, J., WINSTOCK, A. R., & Barratt, M. J. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2599 · Cited by 22
4,4′‐Dimethylaminorex (“4,4′‐DMAR”; “Serotoni”) misuse: A Web‐based study
Loi, B., Zloh, M., Luca, M. A. D., Pintori, N., Corkery, J., & Schifano, F. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2575 · Cited by 22
A two fatal cases of poisoning involving new cathinone derivative PV8
Pieprzyca, E., Skowronek, R., Korczyńska, M., Kulikowska, J., & Chowaniec, M. (2018) · Legal Medicine · doi:10.1016/j.legalmed.2018.05.002 · Cited by 22
DARK Classics in Chemical Neuroscience: Aminorex Analogues
Maier, J., Mayer, F. P., Brandt, S. D., & Sitte, H. H. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00415 · Cited by 22
Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids
Garneau, B., Desharnais, B., Beauchamp-Doré, A., Lavallée, C., Mireault, P., & Lajeunesse, A. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz018 · Cited by 22
Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors
Nguyen, P. T., Dang, D., Tran, H., Shin, E., Jeong, J. H., Nah, S.-Y., Cho, M. C., Lee, Y. S., Jang, C., & Kim, H. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.017 · Cited by 22
Franzén, L., Bäckberg, M., Beck, O., & Helander, A. (2018) · Journal of Medical Toxicology · doi:10.1007/s13181-018-0668-2 · Cited by 21
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model
Foti, F., Marti, M., Ossato, A., Bilel, S., Sangiorgi, E., Botrè, F., Cerbelli, B., Baldi, A., & De‐Giorgio, F. (2018) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1891-8 · Cited by 21
Dopaminergic neurotoxic effects of 3-TFMPP derivatives
Majrashi, M., Almaghrabi, M., Fadan, M., Fujihashi, A., Lee, W., DeRuiter, J., Clark, C. R., & Dhanasekaran, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.052 · Cited by 21
Thorlacius, K., Borna, C., & Personne, M. (2008) · PubMed · Cited by 20
Withdrawal Seizures Seen In the Setting of Synthetic Cannabinoid Abuse
Sampson, C. S., Bedy, S.-M., & Carlisle, T. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.03.025 · Cited by 20
2-Aminoindans of pharmacological interest
Solomons, E. T., & Sam, J. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00270a004 · Cited by 20
“Bath Salts” the New York City Medical Examiner Experience: A 3‐Year Retrospective Review
deRoux, S. J., & Dunn, B. (2016) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13316 · Cited by 20
A Case of Nonfatal Intoxication Associated with the Recreational use of Diphenidine
Gerace, E., Bovetto, E., Corcia, D. D., Vincenti, M., & Salomone, A. (2017) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13355 · Cited by 20
AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema
Maeda, H., Kikura‐Hanajiri, R., Kawamura, M., Nagashima, E., & Yoshida, K. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1340648 · Cited by 20
Mass poisoning with NPS: 2C-E and Bromo-DragonFly
Iwersen‐Bergmann, S., Lehmann, S., Heinemann, A. W., Schröder, C., Müller, A. F., Jungen, H., Andresen‐Streichert, H., Pueschel, K., Vidal, C., & Mercer‐Chalmers‐Bender, K. (2018) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1882-9 · Cited by 20
Mayer, F. P., Cintulová, D., Pittrich, D. A., Wimmer, L., Luethi, D., Holy, M., Jäntsch, K., Tischberger, S. B., Gmeiner, G., Hoener, M. C., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.032 · Cited by 20
Self-citationBanister, S. D., Kevin, R. C., Martin, L. J., Adams, A. J., Macdonald, C. E., Manning, J. J., Boyd, R. A., Cunningham, M. E. A., Stevens, M. Y., McGregor, I. S., et al. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2583 · Cited by 20
McLaughlin, G., Morris, N. M., Kavanagh, P. V., Power, J. D., Twamley, B., O’Brien, J. E., Talbot, B. N., Dowling, G., Mahony, O., Brandt, S. D., et al. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1732 · Cited by 19
Nopaine no gain: Recreational ethylphenidate toxicity
Bailey, G. P., Ho, J. H., Hudson, S. C., Dines, A. M., Archer, J. R. H., Dargan, P. I., & Wood, D. M. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1033062 · Cited by 19
Phenazepam: A review of medico-legal deaths in South Scotland between 2010 and 2014
Shearer, K., Bryce, C., Parsons, M., & Torrance, H. J. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.07.033 · Cited by 19
Lebensgefährliche Intoxikation mit der neuen psychoaktiven Substanz 25C-NBOMe
Grautoff, S., & Kahler, J. P. (2014) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-014-0360-5 · Cited by 19
Mistaking 2C-P for 2C-B: What a Difference a Letter Makes
Stoller, A., Dolder, P. C., Bodmer, M., Hammann, F., Rentsch, K., Exadaktylos, A. K., Liechti, M. E., & Liakoni, E. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw108 · Cited by 19
Self-citationde Jong, L. A. A., Olyslager, E. J. H., & Duijst, W. L. J. M. (2019) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2019.05.011 · Cited by 19
Research works printed but not linked: 5
- Heim R (2004) Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur: Entwicklung eines neuen Struktur-Wirkungskonzepts. Dissertation, Freie Universität Berlin. https://refubium.fu-berlin.de/bitstream/handle/fub188/11995/0_RalfHeimTitelblatt.pdf?sequence=1&isAllowed=y. Accessed 7 Jan 2020
- Sanchez S (1929) Sur un homologue de l’éphédrine. Bull Soc Chim Fr 45:284–286
- Thorlacius K, Borna C, Personne M (2008) Bromo-dragonfly–livsfarlig missbruksdrog. Kan ge vävnadsnekros, visar det första beskrivna fallet. Lakartidningen 105(16):1199–200
- Topeff J, Ellsworth H, Willhite L, Bangh S, Edwards E, Cole J (2011) A case series of symptomatic patients, including one fatality, following 2C-E exposure. Clin Toxicol (Phila) 49:526
- Trachsel D, Lehmann D, Enzensperger C (2013) Phenethylamine: von der Struktur zur Funktion. Nachtschatten Verlag, Solothurn
Cited by
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
(2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001299 · Cited by 78
Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Anghel, D.-M. C., Nițescu, G. V., Tiron, A. T., Guțu, C. M., & Baconi, D. L. (2023) · Molecules · doi:10.3390/molecules28134969 · Cited by 124
A review of synthetic cathinones emerging in recent years (2019–2022)
Kuropka, P., Zawadzki, M., & Szpot, P. (2022) · Forensic Toxicology · doi:10.1007/s11419-022-00639-5 · Cited by 79
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Mohr, A. L. A., Logan, B. K., Fogarty, M. F., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Huestis, M. A., & Ropero-Miller, J. D. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac023 · Cited by 68
Metadata
- Authors
- Luethi, D., & Liechti, M. E.
- Affiliations
- TU Wien (AT)
- University of Basel (CH)
- Corresponding author
- Luethi, Dino
- Venue
- Archives of Toxicology
- Published
- 2020-04
- Volume
- 94
- Issue
- 4
- Pages
- 1085-1133
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC7225206
- OpenAlex
- W3014121938
- Cited by
- 262
- References
- 659
- Citations by year
- 2026: 29 · 2025: 43 · 2024: 43 · 2023: 42 · 2022: 55 · 2021: 35 · 2020: 13
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-03-03)
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 5 d)
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- edoc (University of Basel) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2BSP3_181809)
- Bundesamt für Gesundheit (16.921318)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- new psychoactive substances, mechanism of action, adverse drug reactions, stimulants, cathinone, monoamine transporters, sympathomimetic effects, sedatives, mu-opioid receptor agonism, GABA receptors, cardiorespiratory depression, dissociative drugs, NMDA receptor antagonists, ketamine, synthetic cannabinoids, CB1 receptor, serotonergic psychedelics, 5-HT2A receptor, drug screening, polydrug use
- MeSH terms
- Central Nervous System Stimulants, Cannabinoids, Hallucinogens, Humans, Psychotropic Drugs, Serotonin, Illicit Drugs, Designer Drugs, Molecular Structure, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.